Leerink Partners Cuts Price Target on Alexion Pharma (ALXN) to $216; Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Biotechs Continue to Underperform (IBB)
March 17, 2016 10:28 AM EDTBiotech stocks were pressured Thursday, with NASDAQ Biotechnology Index falling 3%. Weakness outpaced softness in other areas, with Nasdaq composite lower by only 0.45%.
Nasdaq Biotech currently trades at 2537, just north of its year to date low of 2517 -- a level hit on Feb. 11. At that time, Nasdaq traded at... More



